Advertisement
Advertisement
U.S. markets close in 4 hours 48 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Virax Biolabs Group Limited (VRAX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
1.0600-0.1500 (-12.40%)
As of 11:11AM EST. Market open.
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 12/5/2022
Current
Market Cap (intraday)
17.83M
Enterprise Value
17.92M
Trailing P/E
N/A
Forward P/E
N/A
PEG Ratio (5 yr expected)
N/A
Price/Sales (ttm)
712.56
Price/Book (mrq)
N/A
Enterprise Value/Revenue
N/A
Enterprise Value/EBITDA
-10.33

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-93.41%
S&P500 52-Week Change 3-15.89%
52 Week High 329.0000
52 Week Low 31.0600
50-Day Moving Average 31.6896
200-Day Moving Average 34.1947

Share Statistics

Avg Vol (3 month) 32.28M
Avg Vol (10 day) 3242.72k
Shares Outstanding 512.83M
Implied Shares Outstanding 6N/A
Float 84.62M
% Held by Insiders 154.77%
% Held by Institutions 10.50%
Shares Short (Nov 14, 2022) 4457.35k
Short Ratio (Nov 14, 2022) 40.16
Short % of Float (Nov 14, 2022) 46.25%
Short % of Shares Outstanding (Nov 14, 2022) 43.65%
Shares Short (prior month Oct 13, 2022) 438.04k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Mar 30, 2022
Most Recent Quarter (mrq)Mar 30, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-2,453.52%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-1.71M
Diluted EPS (ttm)N/A
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)21.76k
Total Cash Per Share (mrq)0
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.04
Book Value Per Share (mrq)-0.10

Cash Flow Statement

Operating Cash Flow (ttm)-809.07k
Levered Free Cash Flow (ttm)-548.45k
Advertisement
Advertisement